# Quantum Corp: financial statements, quarterly

QMCO · Nasdaq · CIK 709283 · [Technology](/sectors/technology.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/qmco.md) · [Financials](/companies/qmco/financials.md) · [Filings](/companies/qmco/filings.md) · [Insiders](/companies/qmco/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/qmco/financials.md?period=annual).

## Income statement

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [75.7](/filings/0000709283-24-000036.md) | [71.9](/filings/0000709283-25-000003.md) | [71.5](/filings/0000709283-24-000014.md) | [72.3](/filings/0000709283-25-000045.md) | [71.8](/filings/0000709283-25-000085.md) | [68.7](/filings/0001628280-26-008558.md) | [61.3 d](/filings/0001628280-26-045602.md) | [64.3](/filings/0001628280-26-055417.md) | [62.7](/filings/0000709283-25-000085.md) | [74.6](/filings/0001628280-26-008558.md) | [78.0 d](/filings/0001628280-26-045602.md) | [80.8](/filings/0001628280-26-055417.md) |
| Cost of revenue | $m | [42.9](/filings/0000709283-24-000036.md) | [42.7](/filings/0000709283-25-000003.md) | [44.2 d](/filings/0000709283-25-000027.md) | [45.2](/filings/0000709283-25-000045.md) | [41.2](/filings/0000709283-25-000085.md) | [40.8](/filings/0001628280-26-008558.md) | [37.0 d](/filings/0001628280-26-045602.md) | [41.6](/filings/0001628280-26-055417.md) | [39.2](/filings/0000709283-25-000085.md) | [45.7](/filings/0001628280-26-008558.md) | [50.1 d](/filings/0001628280-26-045602.md) | [49.1](/filings/0001628280-26-055417.md) |
| Gross profit | $m | [32.7](/filings/0000709283-24-000036.md) | [29.2](/filings/0000709283-25-000003.md) | [27.3](/filings/0000709283-24-000014.md) | [27.1](/filings/0000709283-25-000045.md) | [30.6](/filings/0000709283-25-000085.md) | [27.9](/filings/0001628280-26-008558.md) | [24.2 d](/filings/0001628280-26-045602.md) | [22.7](/filings/0001628280-26-055417.md) | [23.6](/filings/0000709283-25-000085.md) | [28.9](/filings/0001628280-26-008558.md) | [27.8 d](/filings/0001628280-26-045602.md) | [31.7](/filings/0001628280-26-055417.md) |
| Research and development | $m | [9.2](/filings/0000709283-24-000036.md) | [8.8](/filings/0000709283-25-000003.md) | [9.2 d](/filings/0000709283-25-000027.md) | [8.3](/filings/0000709283-25-000045.md) | [8.3](/filings/0000709283-25-000085.md) | [7.7](/filings/0001628280-26-008558.md) | [6.9 d](/filings/0001628280-26-045602.md) | [6.7](/filings/0001628280-26-055417.md) | [5.7](/filings/0000709283-25-000085.md) | [5.6](/filings/0001628280-26-008558.md) | [5.6 d](/filings/0001628280-26-045602.md) | [6.0](/filings/0001628280-26-055417.md) |
| Operating income | $m | [(3.7)](/filings/0000709283-24-000036.md) | [(6.2)](/filings/0000709283-25-000003.md) | [(13.8)](/filings/0000709283-24-000014.md) | [(16.8)](/filings/0000709283-25-000045.md) | [(5.6)](/filings/0000709283-25-000085.md) | [(7.7)](/filings/0001628280-26-008558.md) | [(11.6) d](/filings/0001628280-26-045602.md) | [(12.6)](/filings/0001628280-26-055417.md) | [(8.2)](/filings/0000709283-25-000085.md) | [(1.2)](/filings/0001628280-26-008558.md) | [(2.6) d](/filings/0001628280-26-045602.md) | [5.0](/filings/0001628280-26-055417.md) |
| Interest expense | $m | [3.9](/filings/0000709283-24-000036.md) | [3.9](/filings/0000709283-25-000003.md) | [4.1 d](/filings/0000709283-25-000027.md) | [3.8](/filings/0000709283-25-000045.md) | [6.1](/filings/0000709283-25-000085.md) | [6.8](/filings/0001628280-26-008558.md) | [6.8 d](/filings/0001628280-26-045602.md) | [6.5](/filings/0001628280-26-055417.md) | [6.2](/filings/0000709283-25-000085.md) | [5.9](/filings/0001628280-26-008558.md) | [2.9 d](/filings/0001628280-26-045602.md) | [2.1](/filings/0001628280-26-055417.md) |
| Income tax | $m | [0.5](/filings/0000709283-24-000036.md) | [0.5](/filings/0000709283-25-000003.md) | [(0.9) d](/filings/0000709283-25-000027.md) | [0.2](/filings/0000709283-25-000045.md) | [0.4](/filings/0000709283-25-000085.md) | [0.1](/filings/0001628280-26-008558.md) | [0.1 d](/filings/0001628280-26-045602.md) | [0.2](/filings/0001628280-26-055417.md) | [0.2](/filings/0000709283-25-000085.md) | [0.6](/filings/0001628280-26-008558.md) | [0.0 d](/filings/0001628280-26-045602.md) | [0.7](/filings/0001628280-26-055417.md) |
| Net income | $m | [(3.3)](/filings/0000709283-24-000036.md) | [(9.9)](/filings/0000709283-25-000003.md) | [(18.9)](/filings/0000709283-24-000014.md) | [(19.9)](/filings/0000709283-25-000045.md) | [(12.2)](/filings/0000709283-25-000085.md) | [(75.3)](/filings/0001628280-26-008558.md) | [(7.7) d](/filings/0001628280-26-045602.md) | [(17.2)](/filings/0001628280-26-055417.md) | [(46.5)](/filings/0000709283-25-000085.md) | [(27.8)](/filings/0001628280-26-008558.md) | [(9.5) d](/filings/0001628280-26-045602.md) | [(155)](/filings/0001628280-26-055417.md) |
| Diluted EPS | $ per share | [(0.70)](/filings/0000709283-24-000036.md) | [(2.08)](/filings/0000709283-25-000003.md) | not reported | [(4.15)](/filings/0000709283-25-000045.md) | [(2.54)](/filings/0000709283-25-000085.md) | [(15.35)](/filings/0001628280-26-008558.md) | not reported | [(1.87)](/filings/0001628280-26-055417.md) | [(3.49)](/filings/0000709283-25-000085.md) | [(2.03)](/filings/0001628280-26-008558.md) | not reported | [(7.06)](/filings/0001628280-26-055417.md) |
| Basic EPS | $ per share | [(0.70)](/filings/0000709283-24-000036.md) | [(2.08)](/filings/0000709283-25-000003.md) | [(0.20)](/filings/0000709283-24-000014.md) | [(4.15)](/filings/0000709283-25-000045.md) | [(2.54)](/filings/0000709283-25-000085.md) | [(15.35)](/filings/0001628280-26-008558.md) | not reported | [(1.87)](/filings/0001628280-26-055417.md) | [(3.49)](/filings/0000709283-25-000085.md) | [(2.03)](/filings/0001628280-26-008558.md) | not reported | [(7.06)](/filings/0001628280-26-055417.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [25.6](/filings/0000709283-24-000036.md) | [24.4](/filings/0000709283-25-000003.md) | [25.7](/filings/0000709283-25-000027.md) | [17.3](/filings/0000709283-25-000045.md) | [16.7](/filings/0000709283-25-000085.md) | [20.4](/filings/0001628280-26-008558.md) | [16.5](/filings/0001628280-26-045602.md) | [37.4](/filings/0001628280-26-055417.md) | [14.7](/filings/0000709283-25-000085.md) | [13.2](/filings/0001628280-26-008558.md) | [15.6](/filings/0001628280-26-055417.md) | [54.4](/filings/0001628280-26-055417.md) |
| Current assets | $m | [134](/filings/0000709283-24-000019.md) | [141](/filings/0000709283-24-000018.md) | [132](/filings/0000709283-25-000027.md) | [119](/filings/0000709283-24-000017.md) | [109](/filings/0000709283-24-000036.md) | [114](/filings/0000709283-25-000027.md) | [103](/filings/0001628280-26-045602.md) | [118](/filings/0000709283-25-000045.md) | [90.1](/filings/0000709283-25-000085.md) | [104](/filings/0001628280-26-008558.md) | [112](/filings/0001628280-26-055417.md) | [149](/filings/0001628280-26-055417.md) |
| Total assets | $m | [195](/filings/0000709283-24-000019.md) | [199](/filings/0000709283-24-000018.md) | [188](/filings/0000709283-25-000027.md) | [173](/filings/0000709283-24-000017.md) | [163](/filings/0000709283-24-000036.md) | [168](/filings/0000709283-25-000027.md) | [155](/filings/0001628280-26-045602.md) | [169](/filings/0000709283-25-000045.md) | [138](/filings/0000709283-25-000085.md) | [149](/filings/0001628280-26-008558.md) | [157](/filings/0001628280-26-055417.md) | [192](/filings/0001628280-26-055417.md) |
| Current liabilities | $m | [231](/filings/0000709283-24-000019.md) | [241](/filings/0000709283-24-000018.md) | [250](/filings/0000709283-25-000027.md) | [151](/filings/0000709283-25-000045.md) | [131](/filings/0000709283-25-000085.md) | [302](/filings/0000709283-25-000027.md) | [258](/filings/0001628280-26-045602.md) | [224](/filings/0000709283-25-000045.md) | [242](/filings/0000709283-25-000085.md) | [203](/filings/0001628280-26-008558.md) | [206](/filings/0001628280-26-055417.md) | [160](/filings/0001628280-26-055417.md) |
| Total liabilities | $m | [289](/filings/0000709283-24-000019.md) | [301](/filings/0000709283-24-000018.md) | [309](/filings/0000709283-25-000027.md) | [313](/filings/0000709283-25-000045.md) | [314](/filings/0000709283-25-000085.md) | [365](/filings/0000709283-25-000027.md) | [320](/filings/0001628280-26-045602.md) | [284](/filings/0000709283-25-000045.md) | [298](/filings/0000709283-25-000085.md) | [334](/filings/0001628280-26-008558.md) | [356](/filings/0001628280-26-055417.md) | [220](/filings/0001628280-26-055417.md) |
| Long-term debt | $m | [0.0](/filings/0000709283-24-000014.md) | [0.0](/filings/0000709283-24-000014.md) | [0.0](/filings/0000709283-24-000014.md) | [101](/filings/0000709283-24-000017.md) | [123](/filings/0000709283-24-000036.md) | [0.0](/filings/0000709283-25-000003.md) | [0.0](/filings/0001628280-26-045602.md) | [0.0](/filings/0000709283-25-000045.md) | [0.0](/filings/0000709283-25-000085.md) | [75.9](/filings/0001628280-26-008558.md) | [90.0](/filings/0001628280-26-055417.md) | [0.0](/filings/0001628280-26-055417.md) |
| Current portion of debt | $m | [82.7](/filings/0000709283-24-000019.md) | [82.6](/filings/0000709283-24-000018.md) | [82.5](/filings/0000709283-25-000027.md) | [5.0](/filings/0000709283-24-000017.md) | [1.6](/filings/0000709283-24-000036.md) | [98.6](/filings/0000709283-25-000027.md) | [96.5](/filings/0001628280-26-045602.md) | [96.7](/filings/0000709283-25-000045.md) | [99.6](/filings/0000709283-25-000085.md) | [52.8](/filings/0001628280-26-008558.md) | [54.8](/filings/0001628280-26-055417.md) | [0.0](/filings/0001628280-26-055417.md) |
| Shareholders' equity | $m | [(94.4)](/filings/0000709283-25-000003.md) | [(102)](/filings/0000709283-25-000003.md) | [(121)](/filings/0001628280-26-045602.md) | [(140)](/filings/0000709283-25-000085.md) | [(151)](/filings/0001628280-26-008558.md) | [(197)](/filings/0001628280-26-008558.md) | [(164)](/filings/0001628280-26-055417.md) | [(114)](/filings/0001628280-26-055417.md) | [(160)](/filings/0001628280-26-008558.md) | [(184)](/filings/0001628280-26-008558.md) | [(199)](/filings/0001628280-26-055417.md) | [(27.8)](/filings/0001628280-26-055417.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent, us-gaap:LongTermDebt
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q4 FY2024 (2024-03-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q4 FY2025 (2025-03-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q4 FY2026 (2026-03-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(1.9) d](/filings/0000709283-24-000036.md) | [(9.4) d](/filings/0000709283-25-000003.md) | [10.6 d](/filings/0000709283-25-000027.md) | [(1.9)](/filings/0000709283-25-000045.md) | [(15.3) d](/filings/0000709283-25-000085.md) | [(3.2) d](/filings/0001628280-26-008558.md) | [(3.3) d](/filings/0001628280-26-045602.md) | [(16.9)](/filings/0001628280-26-055417.md) | [(15.6) d](/filings/0000709283-25-000085.md) | [(4.9) d](/filings/0001628280-26-008558.md) | [(0.4) d](/filings/0001628280-26-045602.md) | [0.9](/filings/0001628280-26-055417.md) |
| Capital expenditure | $m | [1.6 d](/filings/0000709283-24-000036.md) | [1.1 d](/filings/0000709283-25-000003.md) | [0.8 d](/filings/0000709283-25-000027.md) | [1.6](/filings/0000709283-25-000045.md) | [1.6 d](/filings/0000709283-25-000085.md) | [1.1 d](/filings/0001628280-26-008558.md) | [0.6 d](/filings/0001628280-26-045602.md) | [1.2](/filings/0001628280-26-055417.md) | [0.4 d](/filings/0000709283-25-000085.md) | [(0.7) d](/filings/0001628280-26-008558.md) | [0.8 d](/filings/0001628280-26-045602.md) | [0.4](/filings/0001628280-26-055417.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | Q2 FY2023 (2022-09-30) | Q3 FY2023 (2022-12-31) | Q1 FY2024 (2023-06-30) | Q2 FY2024 (2023-09-30) | Q3 FY2024 (2023-12-31) | Q1 FY2025 (2024-06-30) | Q2 FY2025 (2024-09-30) | Q3 FY2025 (2024-12-31) | Q1 FY2026 (2025-06-30) | Q2 FY2026 (2025-09-30) | Q3 FY2026 (2025-12-31) | Q1 FY2027 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [92.8](/filings/0000709283-24-000019.md) | [92.8](/filings/0000709283-24-000018.md) | [93.7](/filings/0000709283-24-000017.md) | [4.8](/filings/0000709283-24-000036.md) | [4.8](/filings/0000709283-25-000003.md) | [4.8](/filings/0000709283-25-000045.md) | [4.8](/filings/0000709283-25-000085.md) | [4.9](/filings/0001628280-26-008558.md) | [9.2](/filings/0001628280-26-055417.md) | [13.3](/filings/0000709283-25-000085.md) | [13.7](/filings/0001628280-26-008558.md) | [22.0](/filings/0001628280-26-055417.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 39,410,001 at 2026-08-06, from the cover of the [10-Q filed 2026-08-11](/filings/0001628280-26-055417.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:22 ET. No prices; not investment advice.